Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the Caenorhabditis elegans Model
Cells · 2023
DOI: 10.3390/cells12182310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Ru-Huei Fu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan. Hauptthemen laut MEDLINE: Neuroblastoma, Neurotoxicity Syndromes, Parkinson Disease, MicroRNAs. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Science and Technology (Taiwan), China Medical University (Taiwan).
Abstract (Originalsprache)
Defective autophagy is one of the cellular hallmarks of Parkinson’s disease (PD). Therefore, a therapeutic strategy could be a modest enhancement of autophagic activity in dopamine (DA) neurons to deal with the clearance of damaged mitochondria and abnormal protein aggregates. Syringin (SRG) is a phenolic glycoside derived from the root of Acanthopanax senticosus. It has antioxidant, anti-apoptotic, and anti-inflammatory properties. However, whether it has a preventive effect on PD remains unclear. The present study found that SRG reversed the increase in intracellular ROS-caused apoptosis in SH-SY5Y cells induced by neurotoxin 6-OHDA exposure. Likewise, in C. elegans, degeneration of DA neurons, DA-related food-sensitive behaviors, longevity, and accumulation of α-synuclein were also improved. Studies of neuroprotective mechanisms have shown that SRG can reverse the suppressed expression of SIRT1, Beclin-1, and other autophagy markers in 6-OHDA-exposed cells. Thus, these enhanced the formation of autophagic vacuoles and autophagy activity. This protective effect can be blocked by pretreatment with wortmannin (an autophagosome formation blocker) and bafilomycin A1 (an autophagosome–lysosome fusion blocker). In addition, 6-OHDA increases the acetylation of Beclin-1, leading to its inactivation. SRG can induce the expression of SIRT1 and promote the deacetylation of Beclin-1. Finally, we found that SRG reduced the 6-OHDA-induced expression of miR-34a targeting SIRT1. The overexpression of miR-34a mimic abolishes the neuroprotective ability of SRG. In conclusion, SRG induces autophagy via partially regulating the miR-34a/SIRT1/Beclin-1 axis to prevent 6-OHDA-induced apoptosis and α-synuclein accumulation. SRG has the opportunity to be established as a candidate agent for the prevention and cure of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
- Translational Medicine Research Center, China Medical University Hospital, Taichung 40447, Taiwan.
- Ph.D. Program for Aging, China Medical University, Taichung 40402, Taiwan.
- Department of Medicine, School of Medicine, China Medical University, Taichung 40447, Taiwan.
- Division of Pediatric Neurology, China Medical University Children's Hospital, Taichung 40447, Taiwan.
ORCID-Profile: Ru-Huei Fu
Förderung
- The Ministry of Science and Technology (Taiwan)
- China Medical University (Taiwan)
Zitieren
APA
Fu, R. H., Hong, S. Y., & Chen, H. J. (2023). Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the Caenorhabditis elegans Model. Cells. https://doi.org/10.3390/cells12182310
Vancouver
Fu RH, Hong SY, Chen HJ. Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the Caenorhabditis elegans Model. Cells. 2023. doi:10.3390/cells12182310
BibTeX
@article{Fu2023,
author = {Fu, Ru-Huei and Hong, Syuan-Yu and Chen, Hui-Jye},
title = {Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the Caenorhabditis elegans Model},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12182310}
}
EUVIMED